Galectin-3 as an early marker of diastolic dysfunction in children with end-stage renal disease on regular hemodialysis

INTRODUCTION AND AIM : Diastolic dysfunction is a common finding in end-stage renal disease (ESRD) on regular hemodialysis (HD). Galectin-3 (Gal-3) has emerged as an early biomarker with diagnostic and prognostic values in cardiac dysfunction with reduced or preserved ejection fraction. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsadek, Akram, Ibrahim, Mohamed, El Fallah, Asmaa Adel, Elian, Mohamed, Deraz, Salem Elsayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802609/
https://www.ncbi.nlm.nih.gov/pubmed/36589658
http://dx.doi.org/10.4103/apc.apc_146_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802609/
https://www.ncbi.nlm.nih.gov/pubmed/36589658
http://dx.doi.org/10.4103/apc.apc_146_21

Ejemplares similares